FDA CIRCULAR NO. ____ Guidelines on the Classification of Deficiencies Observed During Inspection of Drug Distributors, Drugstores, Hospital Pharmacies and Retail Outlet for Non-Prescription Drugs (RONPD); (11 page(s), in English)

Tris(2-chloroethyl) Phosphate (TCEP); Draft Risk Evaluation Under the Toxic Substances Control Act (TSCA); Letter Peer Review; Notice of Availability, Public Meeting and Request for Comment; (3 page(s), in English)

DEAS 835-1: 2025, Bath preparations — Specification — Part 1: Synthetic detergent–based foam baths and shower gels, Third Edition; (12 page(s), in English)